AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
M2 EUROPHARMA-(C)1999-2002 M2 COMMUNICATIONS LTD
Swedish pharmaceutical company Meda AB has signed a long-term licensing agreement with the US company Vivus Inc.
Under the agreement signed by the parties Meda would have exclusive rights to market Vivus' erectile dysfunction drug MUSE in Europe, Meda said.
The European …